TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited has announced the application for the quotation of 53,069 ordinary fully paid securities on the ASX. These securities are issued under an employee incentive scheme, reflecting the company’s ongoing efforts to incentivize and retain talent, which may enhance its operational capabilities and market position.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products that help reduce the risk of infections in healthcare settings.
YTD Price Performance: 48.50%
Average Trading Volume: 792,347
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.36B
For an in-depth examination of NAN stock, go to TipRanks’ Overview page.